ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001383391

New Enterprise Associates 12, Limited Partnership

CIK 0001383391 Name as filed on the most recent filing

Filed as New Enterprise Associates 12, Limited Partnership (29)

37 transaction lines · from 29 filings · filed 2009-03-20 to 2019-11-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

1 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2019-11-27 Proteostasis Therapeutics, Inc.
PTI 		S, Open-market sale 1,166,755 disposed 2.52 2,941,739.38 Form 4, filing 0001209191-19-058418
2019-11-26 Proteostasis Therapeutics, Inc.
PTI 		S, Open-market sale 117,164 disposed 2.45 287,133.81 Form 4, filing 0001209191-19-058418
2018-07-30 Liquidia Technologies Inc
LQDA 		P, Open-market purchase 545,455 acquired 11.00 6,000,005.00 Form 4, filing 0001209191-18-044777
2017-12-18 Proteostasis Therapeutics, Inc.
PTI 		P, Open-market purchase 2,000,000 acquired 5.00 10,000,000.00 Form 4, filing 0001209191-17-066249
2017-07-06 Tintri, Inc.
TNTR 		P, Open-market purchase 926,429 acquired 7.00 6,485,003.00 Form 4, filing 0001209191-17-044680
2017-02-13 Zosano Pharma Corp
ZSAN 		S, Open-market sale 1,099,996 disposed 2.01 2,211,431.96 Form 4, filing 0001209191-17-010557
2016-09-16 Zosano Pharma Corp
ZSAN 		S, Open-market sale 7,471 disposed 0.75 5,603.25 Form 4, filing 0001209191-16-142163
2016-09-14 Proteostasis Therapeutics, Inc.
PTI 		P, Open-market purchase 461,538 acquired 13.00 5,999,994.00 Form 4, filing 0001209191-16-141608
2016-09-13 Zosano Pharma Corp
ZSAN 		S, Open-market sale 10,000 disposed 0.74 7,400.00 Form 4, filing 0001209191-16-141605
2016-08-29 Zosano Pharma Corp
ZSAN 		S, Open-market sale 50,000 disposed 1.01 50,440.00 Form 4, filing 0001209191-16-139316
2016-08-24 Zosano Pharma Corp
ZSAN 		S, Open-market sale 1,200 disposed 1.21 1,452.00 Form 4, filing 0001209191-16-138820
2016-07-21 Zosano Pharma Corp
ZSAN 		S, Open-market sale 8,989 disposed 1.33 11,957.17 Form 4, filing 0001209191-16-133608
2016-07-20 Zosano Pharma Corp
ZSAN 		S, Open-market sale 14,158 disposed 1.24 17,550.26 Form 4, filing 0001209191-16-133608
2016-07-19 Zosano Pharma Corp
ZSAN 		S, Open-market sale 534 disposed 1.17 624.78 Form 4, filing 0001209191-16-133608
2016-07-18 Ardelyx, Inc.
ARDX 		P, Open-market purchase 763,650 acquired 8.73 6,666,664.50 Form 4, filing 0001209191-16-133479
2016-07-13 Zosano Pharma Corp
ZSAN 		S, Open-market sale 13,382 disposed 1.20 16,059.74 Form 4, filing 0001209191-16-132900
2016-02-17 Proteostasis Therapeutics, Inc.
PTI 		P, Open-market purchase 900,324 acquired 8.00 7,202,592.00 Form 4, filing 0001209191-16-099506
2016-01-13 Ardelyx, Inc.
ARDX 		P, Open-market purchase 500,000 acquired 10.00 5,000,000.00 Form 4, filing 0001209191-16-091421
2015-06-05 Ardelyx, Inc.
ARDX 		P, Open-market purchase 1,869,159 acquired 10.70 20,000,001.30 Form 4, filing 0001181431-15-008044
2015-01-30 Zosano Pharma Corp
ZSAN 		P, Open-market purchase 23,457 acquired 11.00 258,027.00 Form 4, filing 0001181431-15-001720
2014-12-10 Trevena Inc
TRVN 		P, Open-market purchase 1,000,000 acquired 4.00 4,000,000.00 Form 4, filing 0001181431-14-038451
2014-08-29 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 11,600 disposed 7.51 87,069.60 Form 4, filing 0001181431-14-030566
2014-08-28 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 146,800 disposed 7.87 1,154,846.24 Form 4, filing 0001181431-14-030566
2014-08-27 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 108,300 disposed 8.17 884,811.00 Form 4, filing 0001181431-14-030566
2014-08-12 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 35,540 disposed 6.76 240,189.98 Form 4, filing 0001181431-14-028995
2014-08-08 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 675,000 disposed 6.62 4,468,567.50 Form 4, filing 0001181431-14-028995
2014-06-24 Ardelyx, Inc.
ARDX 		P, Open-market purchase 510,442 acquired 14.00 7,146,188.00 Form 4, filing 0001181431-14-025055
2014-04-22 TriVascular Technologies, Inc.
TRIV 		P, Open-market purchase 583,333 acquired 12.00 6,999,996.00 Form 4, filing 0001181431-14-016851
2014-02-05 Trevena Inc
TRVN 		P, Open-market purchase 472,410 acquired 7.00 3,306,870.00 Form 4, filing 0001181431-14-005688
2013-11-12 Channeladvisor Corp
ECOM 		S, Open-market sale 903,229 disposed 32.37 29,237,522.73 Form 4, filing 0001181431-13-058742
2013-11-12 Channeladvisor Corp
ECOM 		S, Open-market sale 201,012 disposed 32.37 6,506,758.44 Form 4, filing 0001181431-13-058742
2012-07-31 Hyperion Therapeutics Inc
HPTX 		P, Open-market purchase 500,000 acquired 10.00 5,000,000.00 Form 4, filing 0001181431-12-043183
2011-11-28 Fusion-Io, Inc.
FIO 		S, Open-market sale 1,291,493 disposed 31.68 40,914,498.24 Form 4, filing 0001181431-11-057939
2011-03-10 ARYx Therapeutics, Inc.
ARYX 		S, Open-market sale 4,469,274 disposed 0.07 326,257.00 Form 4, filing 0001181431-11-017713
2010-06-30 Sunesis Pharmaceuticals Inc
SNSS 		P, Open-market purchase 23,824,451 acquired 0.28 6,551,724.02 Form 4, filing 0001181431-10-035797
2009-03-11 Peplin Inc
PLIN 		P, Open-market purchase 5,218.55 acquired 0.49 2,557.09 Form 4, filing 0001181431-09-016730
2009-03-10 Peplin Inc
PLIN 		P, Open-market purchase 10,000 acquired 0.49 4,900.00 Form 4, filing 0001181431-09-016730

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. New Enterprise Associates 12, Limited Partnership, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001383391

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.